Company · CIK 0001347178 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Vanda Pharmaceuticals Inc. · VNDA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 AForm 4 → | Jun 8, 4:39 pm EDT | Daniel Patrick McGuireSVP, GC and Secretary | 80,000 | — | — | 109,982 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:23 pm EDT | Phaedra ChrousosDirector | 41,600 | — | — | 164,950 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:21 pm EDT | Charles Cliff DuncanDirector | 41,600 | — | — | 98,701 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:20 pm EDT | Richard W DuganDirector | 41,600 | — | — | 219,054 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:19 pm EDT | Anne Sempowski WardDirector | 41,600 | — | — | 160,667 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:17 pm EDT | Tage HonoreDirector | 41,600 | — | — | 135,069 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:15 pm EDT | Stephen Ray MitchellDirector | 41,600 | — | — | 112,846 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.